Last $42.46 USD
Change Today +0.22 / 0.52%
Volume 175.5K
NEOG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

neogen corp (NEOG) Snapshot

Open
$42.08
Previous Close
$42.24
Day High
$42.66
Day Low
$42.05
52 Week High
12/10/13 - $51.22
52 Week Low
08/20/13 - $35.41
Market Cap
1.6B
Average Volume 10 Days
205.4K
EPS TTM
--
Shares Outstanding
36.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEOGEN CORP (NEOG)

Related News

No related news articles were found.

neogen corp (NEOG) Related Businessweek News

No Related Businessweek News Found

neogen corp (NEOG) Details

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug and pesticide residues, and general sanitation concerns; and AccuPoint, a bioluminescence-based sanitation test for adenosine triphosphate, a chemical found in living cells. It offers its products primarily to food and feed processors, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, and dairies; laboratories; producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various regulatory agencies. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services to the animal safety market. This segment’s drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm animals and racing animals, such as horses, greyhounds, and camels; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. Its products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. In addition, this segment offers various products for researchers to detect biologically-active substances; and proprietary substrates for other diagnostic test kit manufacturers. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

781 Employees
Last Reported Date: 07/30/13
Founded in 1981

neogen corp (NEOG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $535.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $227.0K
Vice President of Food Safety Operations
Total Annual Compensation: $216.6K
Vice President of Animal Safety Operations
Total Annual Compensation: $203.1K
Compensation as of Fiscal Year 2013.

neogen corp (NEOG) Key Developments

TransAct Partners with Neogen to Add Sanitation Monitoring Solution as Option for New Ithaca(R) 9800 Food Safety Terminal

TransAct Technologies Incorporated announced a partnership with Neogen Corporation pursuant to which TransAct will offer Neogen's AccuPoint(R) ATP (adenosine triphosphate) Sanitation Monitoring technology as an option on its innovative new Ithaca(R) 9800 food safety terminal. Through the partnership, TransAct and Neogen are offering direct integration of the innovative Ithaca 9800 food safety terminal and Neogen's AccuPoint ATP Sanitation Monitoring System. The AccuPoint technology allows food service operators to test food production surfaces after they've been cleaned to measure the effectiveness of that cleaning. The combined device will store and display critical data (including test site name, number, group, as well as the time and date the test was taken) and log test results to enable the real-time verification of sanitation effectiveness, offering a streamlined solution that ensures the cleanliness of food contact surfaces and food processing equipment. Since ATP is present in all living cells, ATP measurement has become the de facto standard for determining the amount of organic material remaining on a surface after cleaning. Using the detection capabilities of the AccuPoint, restaurant and food service operators will have direct access to this powerful technology used by industry restaurant inspectors to ensure cleanliness. Operators will also be able to implement testing schedules into their cleaning programs, executing regularly-timed tests in various areas of their facility, ensuring their programs' effectiveness, and guaranteeing consistency throughout their operations.

Neogen Corp. Presents at 11th Annual Craig-Hallum Institutional Investor Conference, May-28-2014

Neogen Corp. Presents at 11th Annual Craig-Hallum Institutional Investor Conference, May-28-2014 . Venue: Minneapolis Marriott City Center Hotel, 30 South Seventh Street, Minneapolis, MN 55402, United States.

Neogen Corporation Announces Consolidated Unaudited Earnings Results for the Third Quarter and Nine Months Ended February 28, 2014

Neogen Corporation announced consolidated unaudited earnings results for the third quarter and nine months ended February 28, 2014. For the quarter, the company reported total revenue was $61,996,000 against $51,055,000 a year ago. Operating income was $10,293,000 against $9,666,000 a year ago. Income before tax was $10,253,000 against $10,060,000 a year ago. Net income attributable to company was $6,575,000 against $6,652,000 a year ago. Net income attributable to company per diluted share was $0.18 against $0.18 a year ago. For the nine months, the company reported total revenue was $180,143,000 against $151,522,000 a year ago. Operating income was $32,400,000 against $30,470,000 a year ago. Income before tax was $31,878,000 against $31,014,000 a year ago. Net income attributable to company was $20,621,000 against $20,158,000 a year ago. Net income attributable to company per diluted share was $0.56 against $0.55 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEOG:US $42.46 USD +0.22

NEOG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biomerica Inc $0.90 USD 0.00
IDEXX Laboratories Inc $133.61 USD +0.22
Meridian Bioscience Inc $20.58 USD +0.21
OraSure Technologies Inc $8.29 USD -0.10
Siemens Ltd 866.70 INR +12.10
View Industry Companies
 

Industry Analysis

NEOG

Industry Average

Valuation NEOG Industry Range
Price/Earnings 56.8x
Price/Sales 6.6x
Price/Book 5.3x
Price/Cash Flow 56.3x
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGEN CORP, please visit www.neogen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.